Professor Rebecca Eisenberg on BioPharma IP Issues
March 13, 2009 12:45pm - 2:00pm
Rebecca S. Eisenberg is a graduate of Stanford University and Boalt Hall School of Law at the University of California, Berkeley, where she was articles editor of the California Law Review. Following law school she served as law clerk for Chief Judge Robert F. Peckham on the United States District Court for the Northern District of California and then practiced law as a litigator in San Francisco. She joined the University of Michigan Law School faculty in 1984. Professor Eisenberg regularly teaches courses in patent law, trademark law, FDA law, and runs workshops on intellectual property and student scholarship. She has previously taught courses on torts, legal regulation of science, and legal issues in biopharmaceutical research. She has written and lectured extensively about the role of intellectual property in biopharmaceutical research, publishing in scientific journals as well as law reviews. She spent the 1999-2000 academic year as a visiting professor of law, science and technology at Stanford Law School. She has received grants from the program on Ethical, Legal, and Social Implications of the Human Genome Project from the U.S.
Department of Energy Office of Biological and Environmental Research for her work on private appropriation and public dissemination of DNA sequence information. Professor Eisenberg has played an active role in public policy debates concerning the role of intellectual property in biopharmaceutical research. She is a member of the Advisory Committee to the Director of the National Institutes of Health, the Panel on Science, Technology and Law of the National Academies, and the Board of Directors of the Stem Cell Genomics and Therapeutics Network in Canada. Professor Eisenberg is the Robert and Barbara Luciano Professor of Law.
Professor Eisenberg co-organized the Winter 2003 Intellectual Property Workshop.